期刊文献+

甘油三酯与中年冠状动脉粥样硬化病变关系的研究 被引量:4

Study on the relationship between triglyceride and severity of coronary arteriosclerosis lesion in middle age patients
下载PDF
导出
摘要 目的:通过比较中年冠心病患者在甘油三酯(TG)的不同分层下行经皮冠状动脉介入治疗(PCI)术的特点,探讨TG对中年冠心病患者冠脉狭窄严重程度及病变血管范围的影响。方法:⑴对行PCI术并植入金属支架的531例中年冠心病患者(45岁≤年龄<60岁)病历进行回顾性分析。(2)按TG测定结果分为3组:①Ⅰ组:TG<1.70mmol/L,n=234。②Ⅱ组:1.70mmol/L≤TG≤2.25mmol/L,n=114。③Ⅲ组:TG≥2.26mmol/L,n=183。(3)数据处理采用SPSS11.5统计分析软件包进行。结果:⑴Ⅰ组的TC、非HDL-C及空腹血糖明显低于Ⅱ组、Ⅲ组,Ⅱ组的LDL-C明显高于Ⅰ组、Ⅲ组(P<0.05),3组间的HDL-C无差异(P=0.534)。(2)3组患者的病变血管范围、冠脉病变狭窄严重程度差异无统计学意义(P>0.05)。结论:高TG血症可能对中年冠心病患者冠脉狭窄严重程度及病变血管范围影响较小,不是其冠心病严重程度的决定性因素。 Objective: To compare the clinical characteristics in CHD middle age patients (≥45y, 〈 60y)with or without hypertriglyceridemia underwent PCI and evaluate the impact of triglyceride on severity of coronary artery stenosis and the extent. Methods; (1)531 records of middle age patients implanted metal stents were analyzed retrospectively. (2)The patients were divided into three groups according to TG results: Ⅰ group (plasma TG〈1.70mmol/L, n = 234), Ⅱ group (plasma 1.70 mmol/L≤TG ≤2.25 mmol/L, n =114) and m group (TG ≥ 2.26 mmol/L, n = 183). (3)All statistical analyses were performed with SPSS, version 11.5. Results: (1)TC, non-HDL-C and fasting glucose were lower in Ⅰ group than those in Ⅱ, Ⅲ group with statistical significance, there were no significant difference between the three groups in LDL-C. (2) There were no significant difference between the three groups in severity of coronary artery stenosis and regarding the extent of coronary artery. Conclusion; There were no significant difference between the three groups in severity of coronary artery stenosis and regarding the extent of coronary artery, it isn't the determiner on severity of CHD.
作者 刘健 丛洪良
出处 《天津医科大学学报》 2009年第3期444-446,455,共4页 Journal of Tianjin Medical University
关键词 中年 甘油三酯 冠心病 经皮冠状动脉介入治疗 Middle age patients Triglyceride Coronary atherosclerotic heart disease Percutaneous coronary intervention
  • 相关文献

参考文献15

  • 1吉维敏,李晓彤.冠状动脉病变范围、程度与心率变异性的关系[J].实用医学杂志,2007,23(1):70-71. 被引量:27
  • 2吕利雄,诸骏仁,韩琴琴.富含甘油三酯脂蛋白的致冠心病危险性[J].中华心血管病杂志,2001,29(1):58-60. 被引量:54
  • 3陈灏珠.实用内科学[M].北京:人民卫生出版社,1999.394.
  • 4叶任高 陆再英.内科学[M]·第5版[M].北京:人民卫生出版社,2000.465.
  • 5Expert committee on the diagnosis and classification of diabetes mellitus.Report of the expert committee on the diagnosis and classiilcation of diabetes mcllitus[J].Diabetes Care,2003,26 (supl):S5.
  • 6Chobanian AV,Bakris GL,Black HR,et al.Seventh report of the joint national on prevention,detection,evaluation,and treatment of high blood pressure[J].Hypertension,2003,42(6):1206.
  • 7《中国成人血脂异常防治指南》制订联合委员会.中国成人血脂防治指南[M].北京:人民卫生出版社.2007:26-28.
  • 8Inset HS,Purl VK,Narain VS,et al.Lipoprotein (a) and lipid Icyeta in young patients with myocardial infarction and their first-degree relatives[J].Indian Heart J,2001,53 (4):463.
  • 9Sharrett AR,Ballantyne CI,Coady SA,et al.Coronary heart disease prediction from lipoprotein cholesterol levels,triglycerides,lipoprotcin(a),apohpoprotein A-I and B,and HDL denstity subfractions:The atherosclerosis risk in communities (ARIC) study[J].Circulation,2001,104(10):1108.
  • 10Stojilikovic MP,Zhang D,Lopes HF,et al.Hcmodynamic effects of lipids in humans[J].Am]Physiol,2001,280(6):1674.

二级参考文献21

共引文献271

同被引文献37

  • 1邓昌明,黄晶,罗开良,殷跃辉.原发性单纯收缩期高血压患者自主神经活性及其昼夜节律[J].重庆医科大学学报,2004,29(5):675-676. 被引量:6
  • 2李立明,饶克勤,孔灵芝,姚崇华,向红丁,翟凤英,马冠生,杨晓光,中国居民营养与健康状况调查技术执行组.中国居民2002年营养与健康状况调查[J].中华流行病学杂志,2005,26(7):478-484. 被引量:1783
  • 3郭秋景,金政,廉金子.不同级别高血压与颈动脉粥样硬化相关性的超声研究[J].中国超声诊断杂志,2006,7(4):246-248. 被引量:5
  • 4Seo Y,Watanabe S,Ishizu T,et al.Echolucent carotid plaques as a feature in patients with acute coronary syndrome[J].Circ J,2006,70(7):1629-1634.
  • 5Tetsuo Shoji,Sawako Hatsuda,Shoko Tsuchikura,et al.Small dense low – density lipoprotein cholesterol concentration and carotid atherosclerosis[J].Atherosclerosis,2009,202(2):582-588.
  • 6刘力生,龚兰生.中国高血压防治指南(2005年修订版)[M].北京:人民卫生出版社,2006:1~3.
  • 7Burkart D J, Borsa JJ, Anthony JP, et al. Thrombolysis of acute peripheral arterial and enous occlusions with tenecteplase and ep tifibatide:A pilot study. J Vasc Interv Radiol,2003 ,14 :729-733.
  • 8Lemos PA, Serruys PW, van Domburg RT, et al. Unrestricted utilization of sirolimus eluting stents compared with conventional bare stent implan- tation in the "real world", The RaPamycin - Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) Registry. Cicrulation, 2004,109 : 190-95.
  • 9KaPPetein AP, Dwakins KD, Mohr FW, et al. Current Percutaneous coro- nary Intervention and coronary artery bypass gaffing Practices for three- vessel and left Main coronary artery disease. Insihgts from the SYNTAX run-in Phase. Eur J Cardiothorac Surg,2006,29:486-91.
  • 10Ong AT, Serruys PW, Aoki J, et al. The unrestricted use of paclitaxel-ver- sus sirolimus-eluting stent for coronary artery disease in an un-selected population:one-year results of the Taxus-Stent Evaluated at Rotterdam Cardiology Hospital( T-SEARCH ) registry. J Am Coll Cardio1,2005,45 : 1135.

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部